Franklin Resources’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
APM
RCM
FFM
VCM
OCA
TCM
Franklin Resources's DNTH Position: Q1 2026 in Review
Franklin Resources increased its Dianthus Therapeutics (DNTH) stake by 109% in Q1 2026, buying an estimated $29.3M and bringing the position to 968,182 shares worth $81.2M. The position accounts for 0.02% of the portfolio, ranked #489.
Franklin Resources first reported a position in DNTH in Q3 2025 and has held it in 3 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.
- Franklin Resources held 968,182 shares of Dianthus Therapeutics worth $81.2M as of Q1 2026.
- Franklin Resources bought 505,356 Dianthus Therapeutics shares in Q1 2026, an estimated $29.3M.
- Dianthus Therapeutics made up 0.02% of Franklin Resources's portfolio in Q1 2026, its #489 holding.
- Franklin Resources first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 3 quarters since.
- 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.
Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.